RE: If this finishes blue....11 Nov 2020 13:21
from another thread (3 good posts I thought):
andythemkdon
10 Nov '20 - 13:05 - 5214
Hello Aber.. Guess we are over here due to LSE chat not working. All pharma stocks related to Covid have been battered not just Sar. As we know Sar are not a covid play our destiny lies in autoimmune and cancer indications where nothing has changed in our science. Like you I sold very few in the rise to 3p but with no regrets as the real payday comes when Tyk2 hits the clinic and gets licensed. I have added more this morning as I'm expecting a very strong bounce once the vaccine throth has died down. Personally if I'm offered the vaccine I wouldn't have it, its been rushed through on the back of politicians trying to save their faces / jobs and who would trust a politician!! When it's available lets make the MP's the first recipients and see how many want it.. gl fella. Andy.
andythemkdon
10 Nov '20 - 13:53 - 5216
Hello JT.. Hope all is good.. Miss your very succinct one liners over on LSE. ;+) I mailed LSE and they have closed share chat in favour of keeping their live streams opperating, strange they can't run both, guess thats what happens when you put the YTS in charge of IT.. I've always used ADVFN for live data as second to none, however the BB here can sometimes have some "special posters".. !! Meanwhile back at Sar, covid served as a catalyst to get us over 1p however it's just an adjunct to the core business. With news on 737 / Aurora expected and 1801 / 1802 about to hit the clinic there will be plenty of price drivers overthe coming weeks and who knows what will eventually play out in the covid world, vaccines or therapeutics?? Spin the coin.. Personally I think Sar will be acquired in the not to distant future, secure the 1801 patent to add to the 1802 and bingo.. gl fella. Andy.
andythemkdon
10 Nov '20 - 15:32 - 5218
spacedust hi. I would be hoping for somewhere between 7p and 15p on a takeover of the company. If we licence 1801 and 1802 at pre-clinical or early in P I then probably 5p-7p initially rising if we elect to license at an later stage. We will know by the end of the year if 1801 will go into the clinic and then soon after for 1802. We are still waiting upon readouts from Sierra 737 combo trials, and Aurora could throw us a milestone bone within weeks if the Chinese have overcome the soluability issues. Anything else outside of this is a bonus.